NoIR 87% Yellow Fitover Sunglasses Medium U50
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are tinted fitover glasses with a yellow lens that blocks all ultraviolet and blue light while transmitting about 87% of visible light — meaning they brighten and add contrast to the visual field rather than darkening it. They're designed for people with low vision conditions like macular degeneration, cataracts, or other conditions where contrast sensitivity and glare management are priorities, particularly in bright indoor or overcast outdoor environments. The fitover design lets them be worn directly over existing prescription eyeglasses, and side shields reduce peripheral glare. At this light transmission level, these are specifically suited for lower-light situations — for brighter outdoor conditions, NoIR makes darker tints, so make sure this tint percentage fits your typical environment before purchasing.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Slide over prescription glasses or wear alone — ready to use immediately.
- Side shields are built in; no adjustment needed.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.